How much does TEVIMBRA (Tislelizumab Injection) Cost& price without insurance in China?
TEVIMBRA® is the overseas commercial brand name. Its generic English name is Tislelizumab Injection, a humanized anti-PD-1 IgG4 monoclonal antibody independently developed by BeiGene. It blocks PD-1/PD-L1 binding to reactivate body’s own anti-tumor immune T cells, with modified Fc segment to avoid T cell depletion.
Main Indications
Recurrent/refractory classical Hodgkin’s lymphoma after ≥2 lines of chemotherapy;
Locally advanced/metastatic urothelial carcinoma with high PD-L1 expression after platinum-based chemotherapy failure;
Multiple first-line & second-line regimens for non-small cell lung cancer (squamous/non-squamous);
Advanced hepatocellular carcinoma, esophageal squamous cell carcinoma, nasopharyngeal carcinoma, MSI-H/dMMR solid tumors.
Common Side Effects
Mild frequent adverse reactions: Fatigue, hypothyroidism, elevated liver transaminase, anemia, rash, infusion-related fever;
Lab abnormalities: Transient leukopenia, neutropenia and liver function fluctuation;
Severe risks: Immune-related pneumonia, immune hepatitis, colitis and severe hypersensitivity reactions.
Approval Status in China
Officially approved for marketing in China in December 2019, prescription anti-cancer drug included in China’s Category B National Medical Insurance List
Buy TEVIMBRA (Tislelizumab Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
